Skip to main content
. 2022 Sep 22;13(11):1276–1299. doi: 10.1039/d2md00263a

Examples of β-lactamase inhibitors, their β-lactam adjuvant and the β-lactamase class inhibited59,60 (compiled with the aid of the Comprehensive Antibiotic Resistance Database; CARD; https://card.mcmaster.ca)40.

Name of inhibitor β-Lactam β-Lactamase class inhibited Ref.
Approved inhibitors
Clavulanic acid Amoxicillin or ticarcillin Class A, some class D 61, 62
Tazobactam Piperacillin Class A, some class D 63
Sulbactam Ampicillin or cefoperazone Class A 64, 65
Avibactam Ceftazidime Class A, C, D 66
Relebactam Imipenem/cilastatin Class A, C 67, 68
Vaborbactam Meropenem Class A, C 67
Developmental inhibitors in clinical trials
Nacubactam Meropenem – phase I trial Class A, C 69, 70
Zidebactam Cefepime – phase III trial Class A, C 71
ETX2514 Sulbactam – phase II trial Class A, C and some D 72
ETX0282 Cefpodoxime – phase I trial Class A, C 73
LN-1-255 Ceftazidime – phase II trial Class A, D (non-carbapenemases) 74
Enmetazobactam Cefepime – phase III trial Class A 75, 76
Taniborbactam Cefepime – phase II trial Class A, B, C, D 77
VNRX-7145 Cefibutin – phase I trial Class A, C, D 78
LK-157 Cefuroxime – phase I trial Class A, C 78
BLI-489 Piperacillin – phase II trial Class A, C, D 79
d-Captopril Meropenem – phase I trial Class B 80